Literature DB >> 17391250

Deletions of VCX-A and NLGN4: a variable phenotype including normal intellect.

M Macarov1, M Zeigler, J P Newman, D Strich, V Sury, A Tennenbaum, V Meiner.   

Abstract

BACKGROUND: Patients with Xp22.3 interstitial and terminal deletions have been shown to be affected by intellectual disability (ID) or autism. Previously, VCX-A (variably charged protein X-A), located at Xp22.3, was introduced as a gene for ID and its presence was suggested to be sufficient to maintain normal mental development. Recent reports suggest that mutations in NLGN4 (neuroligin 4), located at that same region, are involved in autistic disorders and ID.
METHODS: In the current case study, we clinically and molecularly describe a pedigree of three generations affected by contiguous gene syndrome that includes features of X-linked ichthyosis and Kallmann syndrome.
RESULTS: Molecular analysis revealed the presence of an interstitial deletion spanning approximately 4.5Mb at Xp22.3. The centromeric breakpoint was localized between markers DXS1467 and DXS8051, proximal to KAL-1. The telomeric breakpoint was localized between markers DXS89 and DXS1060, distal to NLGN4. The deletion of VCX-A and NLGN4 in this family prompted us to examine the cognitive functions of our two adult patients using comprehensive intellectual and neurocognitive assessment. Normal intellectual function was found in one patient and mild ID was revealed in the other. Neither patient met any Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition criteria for a pervasive developmental disorder such as autism.
CONCLUSIONS: These findings suggest that deletion of VCX-A and NLGN4 can result in variable phenotypic features and that normal mental development can be achieved despite this deletion, emphasizing the importance of environmental factors and possible modifier genes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391250     DOI: 10.1111/j.1365-2788.2006.00880.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  19 in total

1.  An Autism-Associated Mutation Impairs Neuroligin-4 Glycosylation and Enhances Excitatory Synaptic Transmission in Human Neurons.

Authors:  Thomas P Cast; Daniel J Boesch; Kim Smyth; Alisa E Shaw; Michael Ghebrial; Soham Chanda
Journal:  J Neurosci       Date:  2020-12-02       Impact factor: 6.167

2.  Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2.

Authors:  Markus Wöhr; Jill L Silverman; Maria L Scattoni; Sarah M Turner; Mark J Harris; Roheeni Saxena; Jacqueline N Crawley
Journal:  Behav Brain Res       Date:  2012-07-20       Impact factor: 3.332

Review 3.  Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders.

Authors:  Emanuela Santini; Eric Klann
Journal:  Sci Signal       Date:  2014-10-28       Impact factor: 8.192

4.  Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons.

Authors:  Samuele G Marro; Soham Chanda; Nan Yang; Justyna A Janas; Giulio Valperga; Justin Trotter; Bo Zhou; Sean Merrill; Issa Yousif; Hannah Shelby; Hannes Vogel; M Yashar S Kalani; Thomas C Südhof; Marius Wernig
Journal:  Neuron       Date:  2019-06-27       Impact factor: 17.173

5.  Systematic genotype-phenotype analysis of autism susceptibility loci implicates additional symptoms to co-occur with autism.

Authors:  Jacobine E Buizer-Voskamp; Lude Franke; Wouter G Staal; Emma van Daalen; Chantal Kemner; Roel A Ophoff; Jacob As Vorstman; Herman van Engeland; Cisca Wijmenga
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

6.  Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.

Authors:  E Ey; M Yang; T Bourgeron; J N Crawley; A M Katz; L Woldeyohannes; J L Silverman; C S Leblond; P Faure; N Torquet; A-M Le Sourd
Journal:  Genes Brain Behav       Date:  2012-10-10       Impact factor: 3.449

7.  Modulation of neuritogenesis by a protein implicated in X-linked mental retardation.

Authors:  Xinfu Jiao; Hongxin Chen; Jianmin Chen; Karl Herrup; Bonnie L Firestein; Megerditch Kiledjian
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

Review 8.  Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation.

Authors:  Audrey Guilmatre; Christèle Dubourg; Anne-Laure Mosca; Solenn Legallic; Alice Goldenberg; Valérie Drouin-Garraud; Valérie Layet; Antoine Rosier; Sylvain Briault; Frédérique Bonnet-Brilhault; Frédéric Laumonnier; Sylvie Odent; Gael Le Vacon; Géraldine Joly-Helas; Véronique David; Claude Bendavid; Jean-Michel Pinoit; Céline Henry; Caterina Impallomeni; Eva Germano; Gaetano Tortorella; Gabriella Di Rosa; Catherine Barthelemy; Christian Andres; Laurence Faivre; Thierry Frébourg; Pascale Saugier Veber; Dominique Campion
Journal:  Arch Gen Psychiatry       Date:  2009-09

Review 9.  Neuroligins and neurexins link synaptic function to cognitive disease.

Authors:  Thomas C Südhof
Journal:  Nature       Date:  2008-10-16       Impact factor: 49.962

10.  A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export.

Authors:  Chen Zhang; Jeff M Milunsky; Stephanie Newton; Jaewon Ko; Geping Zhao; Tom A Maher; Helen Tager-Flusberg; Marc F Bolliger; Alice S Carter; Antony A Boucard; Craig M Powell; Thomas C Südhof
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.